86 funding opportunities are listed in this category
Big Questions in Free Will Grants Program
In January, 2010, with the support of a generous grant from the John Templeton Foundation, Florida State University launched a four-year project on free will — Big Questions in Free Will — directed by Alfred R. Mele, William H. and Lucyle T. Werkmeister Professor of Philosophy at Florida State University.The primary purpose of the project is to improve our understanding of free will in three spheres: science (especially neuroscience and social psychology); philosophy; and theology.Those interested in the BQFW project are encouraged to look also at the opportunity for grant funding currently available on the John Templeton Foundation website. The Foundation is offering funds for research on projects investigating (a) the evolution of free will or (b) factors that serve to enhance or diminish our abilities to exercise free will. Initial inquiries are due by April 15, 2010.
Budget range and term for individual projects: From $50,000 to $250,000 and for up to two years.
2010 Thomas E. Heftler Migraine Research Award
The American Headache Society® (AHS) and the Migraine Research Foundation (MRF) announce the 2010 Thomas E. Heftler Migraine Research Award. The $10,000 award will recognize the most innovative research proposal in migraine by a neurology resident or headache medicine fellow in an accredited U.S. program. Both clinical and basic science proposals will be considered. Reviewers will look for innovation, impact, and importance to the field of migraine research.The Migraine Research Foundation created and funded the award in memory of Mr. Heftler who was a founding member of the Board of Directors of the Migraine Research Foundation until his untimely death in June 2007. The Migraine Research Foundation is the only organization whose sole purpose is to raise funds for innovative scientific research to further the understanding of the causes and mechanisms of migraine, to develop improvements in treatment, and to find the cure.The American Headache Society® is a professional organization comprised of physicians and other health care professionals dedicated to improving the care and lives of headache sufferers.The criteria are: (1) the quality of the research proposal; (2) the potential for the research to contribute to the advancement of the field of headache medicine; and (3) the quality of the research environment. Awardees must submit a progress report after 6 months of work, an abstract to the 2012 AHS Annual Scientific Meeting to be reviewed for presentation, and a manuscript based on this work to the journal Headache. Headache has the first right of refusal for the manuscript.To be considered for this award, the completed application form and all supporting documents must be received by the AHS Executive Offices no later than 5:00pm EST on March 25, 2010. * Proposals due March 25, 2010 * Winner announced April 15, 2010 * Award research to commence July 1, 2010Please contact the American Headache Society® if you have any questions.American Headache Society®19 Mantua Rd.Mount Royal, NJ 08061Phone: 856-423-0043Fax: 856-423-0082ahshq@talley.com
International Rett Syndrome Foundation HeART Award (Help Accelerate Rett Therapeutics)
Goal: To provide seed funding for early stage drug discovery and development efforts.Funding: The program provides funding in amounts ranging from $25,000-$50,000 for one year with a high likelihood of follow-on funding for successful programs.HeART Award Timeline
Cycle 1 LOIS due: March 26, 2010Applications due: April 26, 2010
Cycle 2
LOIs due: August 16, 2010Applications due: September 30, 2010
International Rett Syndrome Foundation 4600 Devitt DriveCincinnati OH 45246Telephone: 1-800-818-7388Fax: 1-513-874-2520
2010 Award for Research in Psychiatry Call for Submissions The American Psychiatric Association takes pleasure in inviting submissions for the 2010 American Psychiatric Association Award for Research in Psychiatry. First awarded in 1949 as The Hofheimer Prize, this is the most significant award given for research by the American Psychiatric Association. It is given in recognition of a single distinguished contribution, a body of work, or a lifetime contribution that has had a major impact on the field and/or altered the practice of psychiatry. The Award is intended to cover the full spectrum of psychiatric research. The Award consists of a $5,000 prize and an honorary plaque to be presented at APA's Annual Meeting in May. The Award also includes an honorary lecture by the awardee. Candidates for the Award must be citizens of the United States or Canada and be nominated by a sponsor. Sponsors must be members of the American Psychiatric Association. Members of the Award Committee are excluded from submitting nominations. The sponsor should submit a letter setting out in detail the justification for the nomination, summarizing the nominee's research accomplishments in a specific area, or the coherent theme of the research. The nominee should submit: A summary statement emphasizing the principle theme running through the work, its internal cohesiveness and consistency, and scientific implications An up-to-date Curriculum Vitae, and An up-to-date Bibliography.
Please note that it is no longer necessary for applicants to submit copies of relevant books and/or journal articles.All entries should be submitted electronically to Harold Goldstein, Ph.D., APA Division of Research, email: goharold@psych.org The Award is based on an annual competition and awardees are selected by APA's Committee on Research Awards, Stuart C. Yudofsy, M.D., Chair. Prior applicants who wish to reapply may do so by resubmitting in the next award cycle. For more information please contact Harold Goldstein, Ph.D., by email or by phone at (703) 907-8623. Deadline for receipt of submissions is August 27, 2010
American Psychiatric Association 1000 Wilson Boulevard Suite 1825 Arlington, VA 22209 Questions? Contact APA Answer Center Call Toll-Free: 1-888-35-PSYCH or 1-888-35-77924 From outside the U.S. and Canada call: 1-703-907-7300 Email: apa@psych.org
American Psychiatric Association and the American Association of Chairs of Departments of Psychiatry Research Mentorship Award: Call for Submissions
On behalf of the American Psychiatric Association and the American Association of Chairs of Departments of Psychiatry, we are inviting submissions for the 2010 APA/AACDP Research Mentorship Award. This award honors an academic psychiatrist who has in a significant traditional or innovative manner, fostered the pursuit of student research within his/her university department. The nominee’s contribution may be through direct mentorship of individual students, or by the promotion of novel research-oriented training activities within a department or residency program. The award consists of an inscribed plaque and a $1,500 honorarium, to be presented at the APA Annual Meeting. Only one nomination from any department will be considered. Candidates for the award need not be limited to senior, well-established candidates; innovativeness and dedication will be honored any academic level. Nominees must be members of APA. The award recipient will be selected by the APA Committee on Research Awards, Stuart C. Yudofsky, M.D., Chair. The nomination package, which should be submitted electronically, should include: A nomination letter describing the contribution(s) of the nominee to the department/residency program and/or to the people mentored. A representative list of mentees or other beneficiaries of a specific research training program fostered by the nominee. The nominee’s curriculum vitae. The nomination package should be submitted to Harold Goldstein, Ph.D., APA Division of Research: email: goharold@psych.org telephone: (703) 907-8623 Please note the Submission Deadline of Friday, August 27, 2010.
American Psychiatric Association 1000 Wilson Boulevard Suite 1825 Arlington, VA 22209
Questions? Contact APA Answer Center Call Toll-Free: 1-888-35-PSYCH or 1-888-35-77924 From outside the U.S. and Canada call: 1-703-907-7300 Email: apa@psych.org
BD Biosciences Research Grant Program
Grant applications can be submitted by US scientists focused on stem cell research, multicolor flow cytometry, cell signaling, cancer research, immune function, infectious diseases, or neuroscience research. The BD Biosciences Research Grant Program aims to reward and enable important research by providing vital funding for scientists pursuing innovative experiments to advance the scientific understanding of disease. Through its grant program, BD Biosciences works to support innovation in research and development, helping to define the next generation of scientific breakthroughs. How to Apply The application process is simple. Just write an abstract, complete the online application, review and accept the program terms and conditions, and submit. Important Dates Application start date: May 8, 2010 Application deadline: September 3, 2010 Winners to be announced December 11, 2010
Application Guidelines We welcome your most innovative ideas and encourage you to submit abstracts within evolving research areas that include: Stem cell research Multicolor flow cytometry Cell signaling Cancer research Immune function Infectious diseases Neuroscience research
Applications will be judged by a panel of distinguished scientists from academic and other research institutions. Awards will be based on the application's creativity, content, and innovation, including how you propose to use BD Biosciences reagents to further your research study's goals. Before receiving awards, winners must sign a contract and other forms confirming eligibility and agreeing to abide by the rules of the grant. BD 1 Becton Drive Franklin Lakes, New Jersey USA, 07417 201.847.6800
BD Biosciences 2350 Qume Drive San Jose, California USA, 95131 877.232.8995
Friedreich's Ataxia Research Alliance New Investigator Grants
These grant awards are for young or new investigators who have demonstrated an interest in FA research and want to further that commitment. We believe in welcoming, mentoring and supporting new scientists in the FA research community so that they have the necessary experience and motivation to launch successful independent careers. Guidelines for New Investigator Grants New Investigator Grants are accepted twice a year March 1st and September 1st then awards are announced June 1st and December 1st. The terms of the awards are July 1 – June 30 for awards submitted March 1st and January 1 – December 31 for awards submitted September 1st. Grant proposals should not exceed 24 months in duration. Grant awards are made in one year allocations. All subsequent payments are contingent upon receipt and satisfactory review of a progress report. FARA reserves the right terminate any grant award for inadequate progress, failure to submit reports, deviation in scope of the original research, and/or changes in funding priority. All grants should be submitted using FARA’s Research Portfolio Management Program – www.curefa.org/rpmp On the Main Grant Page of the application please indicate “NIA” in the RFP field. A letter of support should be provided by the applicant’s supervisor/advisor. A personal statement from the applicant should also be included that addresses the applicant’s current interests, career goals and interest in Friedreich’s ataxia research. FARA only funds direct costs. No indirect costs will be awarded. A detailed budget must be submitted with all proposals, including a justification to support reported expenses. Reasonable and customary salary support and benefits are acceptable for the applicant. The budget should not exceed $100,000. Additional allowable expenses include: laboratory reagents and supplies, equipment, animal expenses, patient expenses directly related to study and not reimbursable by third party insurers, patient travel Expenses not awarded: indirect costs/overhead, travel to meetings and conferences, membership to scientific societies Individuals who receive this award cannot reapply through this same mechanism. This award is intended to help the scientist achieve additional sources of funding and independence. If human subjects are used in the proposed study, the study must be approved by the Institutional Review Board (IRB). Full funding will not be provided until proof of IRB approval is demonstrated to FARA. Human subjects studied in the course of research conducted under a grant are under no circumstances a responsibility of FARA. If animals are used in the proposed study, the study must be approved by the Institutional Animal Care and Use Committee (or equivalent) indicating that appropriate precautions have been taken to assure that proper treatment, care and humane conditions have been provided.
Friedreich's Ataxia Research Alliance 102 Pickering Way, Suite 200 Exton, PA 19341 USA Phone: (484) 875-3015 Fax: (610) 363-1506 Email: info@cureFA.org Website: www.cureFA.org
CUREPSP Society for Progressive Supranuclear Palsy Investigator-Initiated Research Projects
Grant submission deadline is April 1, 2010 Two, CBD-related grants are available for up to $75,000 for a period of one to two years
VISION Cure and prevent PSP and CBD
MISSION STATEMENT Increase awareness of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), fund research toward a cure and prevention, educate health professionals, and provide support, information and hope for persons and families with PSP and CBD.
The Society for Progressive Supranuclear Palsy (CurePSP) Research Program supports and promotes research that can advance the understanding and treatment of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).
INVESTIGATOR-INITIATED RESEARCH CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular, cellular, and clinical levels.
CurePSP is particularly interested in research that will help us: 1. Understand the role of the tau gene and other genes in PSP and CBD. 2. Understand the role of tau protein processing in PSP and CBD. 3. Understand cellular energy metabolism and oxidative stress perturbations in PSP and CBD. 4. Understand environmental factors that influence the development or course of PSP and CBD. 5. Understand the series of changes brain cells pass through in PSP and CBD as they progress from healthy neurons to dysfunctional neurons. 6. Characterize the natural history of PSP and CBD in order to develop outcome measures for clinical trials. 7. Develop animal models of PSP and CBD. 8. Develop tools and disease markers for early diagnosis of PSP and CBD and for assessment of treatment. 9. Develop treatments that improve the symptoms of persons with PSP and CBD. 10. Develop interventions to arrest the progression of PSP and CBD and restore lost function.
CurePSP Executive Plaza III 11350 McCormick Road, Suite 906 Hunt Valley, MD 21031 Phone: 800-457-4777 E-mail: info@curepsp.org Website: www.curepsp.org
123456789next
